JDD Article Highlights The launch of the Health Care Administration Leadership and Management (HALM) subspecialty in 2023 is poised to redefine leadership in dermatology. Supported by the American Board of…
Read More
JDD Article Highlights Cutaneous collagenous vasculopathy (CCV), a rare microangiopathy affecting the lower extremities, lacks a well-defined treatment. However, case reports suggest vascular laser therapy may reduce CCV-associated telangiectasias. In…
Read More
JDD Article Highlights From teledermatology to total body photography, digital advancements have reshaped dermatology—but often at a steep cost. Could the widespread adoption of LiDAR technology on smartphones change that?…
Read More
JDD Article Highlights Dermatology thrives on visuals, making it a natural fit for social media. Yet, most dermatology-related content online isn’t from board-certified dermatologists. How can the specialty take charge?…
Read More
JDD Article Highlights Scarring alopecia, marked by irreversible hair follicle damage, is notoriously difficult to treat. While immunomodulatory therapies are the cornerstone, emerging evidence suggests platelet-rich plasma (PRP) may help…
Read More
JDD Article Highlights Lentigo maligna (LM) and its more invasive form, lentigo maligna melanoma (LMM), are increasingly on dermatologists' radar, especially for elderly patients with sun-damaged skin. Historically, the treatment…
Read More
JDD Highlights Active ingredients play a critical role in the efficacy and safety of cosmeceuticals. Join Dr. DiAnne Davis, as she shares information on a new cosmeceutical formulation. This presentation…
Read More
JDD Podcast Atopic Dermatitis (AD) is the second most common chronic inflammatory (coming for you acne!) which unapologetically imparts a tremendous burden on society as a whole. But what if…
Read More
JDD Article Highlights Active ingredients play a critical role in the efficacy and safety of cosmeceuticals. Join Dr. Rosalyn George, as she shares information on a new cosmeceutical formulation. This…
Read More
JDD Article Highlights This article from November’s JDD study reveals a potential game-changer in the fight against Androgenetic Alopecia (male pattern baldness). Researchers compared two popular treatments for hair regrowth,…
Read More
JDD Article Highlights A powerful new contender in the fight against hyperpigmentation is making waves—Isobutylamido Thiazolyl Resorcinol (ITR). Recent studies reveal its potential as a potent inhibitor of human tyrosinase,…
Read More
By Allison Sit The American Academy of Dermatology (AAD) is joining with other specialties in speaking out about cuts to the Medicare Physician Fee Schedule for 2025. The physician services…
Read More
